Please login to the form below
Biotech profile
This page shows the latest Biotech profile news and features for those working in and with pharma, biotech and healthcare.
Sanofi set to acquire Kiadis for €308m
Acquisition will see French pharma gain access to NK-cell platform. French pharma Sanofi is set to buy Kiadis for a total of 308 ($358m) for access to the biotech’s ... We believe this transaction represents compelling value to shareholders and offers
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Biotech profile: Tom Evans, CEO, Vaccitech.
Tom Evans. Pharma Market Europe talks to its chief executive Tom Evans, a veteran research and business leader in viral diseases, with experience across academia, big pharma and biotech. ... Our VTP-100 vaccine has the potential to fulfil this target
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines. ... and sustainable clinical pipeline and a robust product engine by the end of 2020; a company profile rarely, if ever, achieved in
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
